Waycross Partners’s Merck MRK Stock Holding History

Waycross Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$301K	Hold	2,500	–	–	0.03%	65
2025 Q4	$263K	Hold	2,500	–	–	0.02%	90
2025 Q3	$210K	Sell	2,500 -2,000	-44%	-$165K	0.02%	93
2025 Q2	$356K	Sell	4,500 -23,000	-84%	-$1.83M	0.03%	79
2025 Q1	$2.47M	Hold	27,500	–	–	0.28%	41
2024 Q4	$2.74M	Hold	27,500	–	–	0.35%	38
2024 Q3	$3.12M	Buy	27,500 +3,000	+12%	+$356K	0.43%	36
2024 Q2	$3.03M	Buy	24,500 +5,000	+26%	+$644K	0.47%	37
2024 Q1	$2.57M	Hold	19,500	–	–	0.44%	38
2023 Q4	$2.13M	Buy	19,500 +14,000	+255%	+$1.45M	0.4%	45
2023 Q3	$566K	Hold	5,500	–	–	0.13%	76
2023 Q2	$635K	Sell	5,500 -103	-2%	-$11.7K	0.14%	74
2023 Q1	$596K	Hold	5,603	–	–	0.17%	70
2022 Q4	$622K	Buy	5,603 +103	+2%	+$10.5K	0.23%	67
2022 Q3	$474K	Hold	5,500	–	–	0.32%	71
2022 Q2	$501K	Hold	5,500	–	–	0.33%	68
2022 Q1	$451K	Hold	5,500	–	–	0.26%	74
2021 Q4	$422K	Hold	5,500	–	–	0.24%	78
2021 Q3	$413K	Buy	+5,500	New	+$418K	0.26%	80
2021 Q2	–	Sell	-5,764	Closed	-$424K	–	88
2021 Q1	$424K	Hold	5,764	–	–	0.24%	75
2020 Q4	$450K	Buy	+5,764	New	+$441K	0.28%	70

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Waycross Partners's MRK Position: Q1 2026 in Review

Waycross Partners held its Merck (MRK) position steady in Q1 2026 at 2,500 shares worth $301K. The position accounts for 0.03% of the portfolio, ranked #65.

Waycross Partners first reported a position in MRK in Q4 2020 and has held it in 21 quarters since. The position peaked at $3.12M in Q3 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Waycross Partners held 2,500 shares of Merck worth $301K as of Q1 2026.
Waycross Partners left its Merck share count unchanged in Q1 2026.
Merck made up 0.03% of Waycross Partners's portfolio in Q1 2026, its #65 holding.
Waycross Partners first reported a position in Merck in Q4 2020 and has held it in 21 quarters since.
Waycross Partners's Merck position peaked at $3.12M in Q3 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Waycross Partners's 13F filing for Q1 2026, filed 7 May 2026.